Achieve Life Sciences, Inc. (ACHV)

Nasdaq: ACHV · In Vitro & In Vivo Diagnostic Substances · Seattle, WA · filing with the SEC since 1996

Full chart Alerts Compare

Grade4.6

◀ Past 4.2● Present 3.1▶ Future 6.2

6 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Who owns Achieve Life Sciences, Inc.

As filed with the SEC

Holders of 5% or more

Tpg Gp A, LLC holds 12.6% of Common Stock, par value $0.001 per share, as its SCHEDULE 13D filed Apr 24, 2026 says.

Directors and officers

report now, of 32 people on the record since 2008. Their holdings as a group are not read here.

Institutions as a whole

n/a

The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 11 named at left.

Holders of 5% or moreshare of the class, as filed

Tpg Gp A, LLC

SCHEDULE 13D · filed Apr 24, 2026 · Common Stock, par value $0.001 per share

12.6%

Logos Global Management LP

SCHEDULE 13G · filed Aug 17, 2026 · Common Stock

9.99%

venBio Global Strategic Fund V, L.P.

SCHEDULE 13D · filed Apr 27, 2026 · Common Stock, par value $0.001 per share

9.99%

Paradigm BioCapital Advisors LP

SCHEDULE 13G · filed Apr 24, 2026 · Common Stock, $0.001 par value per share

9.2%

Franklin Resources, Inc.

SCHEDULE 13G/A · filed Jul 28, 2026 · Common Stock, par value $0.001 per share · 6.2% in May 7, 2026

8.3%

Frazier Life Sciences Public Fund, L.P.

SCHEDULE 13G · filed Apr 24, 2026 · Common Stock, par value $0.001 per share

6.5%

Alyeska Investment Group, L.P.

SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · 9.9% in Aug 14, 2025

5.6%

JANUS HENDERSON GROUP Ltd.

SCHEDULE 13G · filed Aug 13, 2026 · Common Stock

5.4%

Venrock Healthcare Capital Partners III, L.P.

SCHEDULE 13G · filed Apr 24, 2026 · Common Stock, par value $0.001 per share

5.2%

Blackrock, Inc.

SCHEDULE 13G · filed Jul 27, 2026 · Common Stock · 0.6% in Jul 16, 2025

5.1%

Vivo Opportunity, LLC

SCHEDULE 13G · filed Jul 8, 2026 · Common Stock, par value $0.001 per share

The Vanguard Group

SCHEDULE 13G/A · filed Apr 30, 2025 · Common Stock · reported falling below 5%

under 5%

Parker Quillen

SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%

under 5%

What ACHV reports owning in othersstakes of 5% or more, and other ties

4 subsidiaries in 3 countries, from the list filed with the 10-K filed Mar 24, 2026.

Insider tradesForm 4

1sales

0purchases

0sales on a scheduled plan

1people selling

$200,000sold, in dollars

$0bought, in dollars

Open-market trades on Form 4 from Oct 6, 2025 to Oct 6, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.

By calendar yearSoldBought

1619212223242526

2026 runs to Oct 6, 2026. Dollars as filed, summed by the transaction date.

People who traded in the window1 of 49 on the roster

Person	Role as filed	Sales	Sold	On a plan	Buys	Bought
Stewart Richard Alistair	Chief Executive Officer	1	$200,000	0	0	$0

SI Assistanton ACHV · research, not advice